Viewing Study NCT05563467


Ignite Creation Date: 2025-12-25 @ 12:55 AM
Ignite Modification Date: 2025-12-25 @ 11:10 PM
Study NCT ID: NCT05563467
Status: RECRUITING
Last Update Posted: 2025-04-02
First Post: 2022-08-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module